Navigation Links
Ardea Biosciences, Inc. Reports Third Quarter 2007 Operating and Financial Results
Date:11/14/2007

rry D. Quart, President and CEO. "We made significant progress in advancing our business and in the development of our pipeline, achieving several important milestones." These include:

-- Completion of Phase 1 single-ascending-dose, multiple-ascending-dose,

food-effect, and drug-interaction clinical studies of RDEA806, our lead

non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV, in

August of 2007;

-- Presentation of four posters describing the favorable results of

preclinical and Phase 1 clinical trials with RDEA806 during the 47th

Annual Interscience Conference on Antimicrobial Agents and Chemotherapy

(ICAAC);

-- Completion, submission and FDA approval of our investigational new drug

application (IND) for our lead mitogen-activated ERK kinase (MEK)

inhibitor, RDEA119, allowing us to proceed to Phase 1 clinical trials

in advanced cancer patients; and

-- Presentation of RDEA119 preclinical data, showing favorable properties,

including oral dosing, excellent selectivity and low central nervous

system (CNS) penetration, at the American Association of Cancer

Research (AACR), National Cancer Institute (NCI) and European

Organization for Research and Treatment of Cancer (EORTC) International

Conference on Molecular Targets and Cancer Therapeutics.

"We are well positioned for continued progress and success with our development programs in viral diseases, cancer and inflammatory diseases and are working to achieve several milestones in the next few months," added Dr. Quart. These include:

-- Initiation of a Phase 2a proof-of-concept trial with our lead NNRTI,

RDEA806;

-- Assessing a next-generation NNRTI from our follow-on program in a

first-in-human micro-dosing study;

-- Initiation of a Phase 1 advanced cancer clinical study of our lead MEK

inhibitor, RDEA119;'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
2. Ardea Biosciences Announces Changes to Research Management
3. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
4. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
5. Pressure BioSciences, Inc. Issued First Patent in Canada
6. Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320
7. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
8. Pressure BioSciences, Inc. Provides Corporate Update
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. QMed, Inc. Reports July Medicare SNP Enrollments
11. Phlo Affiliate Reports Expanded Coverage to Oregon Border
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... BELLINGHAM, Washington, USA (PRWEB) September 16, 2014 ... how to create the features that we desire in ... Technology Center at Montana State University. “As we explore ... , Some of those lessons were presented in San ... Nature of Light: Light in Nature ” chaired by ...
(Date:9/16/2014)... Sept. 16, 2014  Biocom, the association representing the ... recognizes the 9 th Annual National Health Information ... IT technologies in improving our health care system. ... one of the world,s most vibrant hubs for health ... health applications to genomic testing to remote patient monitoring," ...
(Date:9/16/2014)... Rice University scientists who created a deicing film for ... as a transparent coating for glass. , The ... colleagues could keep glass surfaces from windshields to skyscrapers ... to radio frequencies (RF). , The technology was ... Applied Materials and Interfaces . , The ...
(Date:9/16/2014)... N.Y. , Sept. 16, 2014  Donald Fresne, President ... appointment of Stephan Vagner , PhD to its Scientific ... University of Toulouse, France , performed research ... , and at Inserm, the French institute of health ... and works both at the Curie Institute, Orsay, ...
Breaking Biology Technology:Nature’s designs inspire research into new light-based technologies 2Nature’s designs inspire research into new light-based technologies 3Nature’s designs inspire research into new light-based technologies 4Nature’s designs inspire research into new light-based technologies 5Biocom Recognizes National Health IT Week 2Nanoribbon film keeps glass ice-free 2New Appointment to the Scientific Advisory Committee at Egenix, Inc. 2
... announced today that its,Chief Financial Officer, Rick McCook, will ... July 2006., "I have enjoyed my work with ... my tenure," said McCook. "However, at this time I,intend ... to,more fully leverage my skills and experience.", "During ...
... 18 Osteotech, Inc.,(Nasdaq: OSTE ), a ... for,regenerative medicine, announced today that it has renewed ... Transplant Alliance,("EATA"), a Bulgarian public non-profit foundation. The ... an initial term of seven years and,automatically renews ...
... 18 ev3 Inc. (Nasdaq:,EVVV) will release its 2008 ... regular market trading hours., The company will host ... a.m. CT (8:30 a.m. ET). ev3 management will review ... a question and answer,session., The conference call will ...
Cached Biology Technology:Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 2Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 3
(Date:9/16/2014)... morbidity amongst women in Australia is increased by ... today (17 September) in BJOG: An International ... generally enjoy high standards of living; however, existing ... particular between indigenous and non indigenous Australians. , ... impact of socioeconomic position on severe maternal morbidities ...
(Date:9/16/2014)... $100 trillion in cumulative public and private spending, ... 40 percent reduction of urban passenger transport emissionscould ... public transportation, walking and cycling in cities, according ... of California, Davis, and the Institute for Transportation ... estimated 1.4 million early deaths could be avoided ...
(Date:9/16/2014)... September 13, 2014. The fire is human-caused and ... acres in size and is mostly being fueled by ... Monday night due to higher humidity. Yesterday (8/15), ... to construct a fireline on the West and North sides ... the fire: , 7 20-person Crews, 4 Hot Shot Crews, ...
Breaking Biology News(10 mins):New study examines the impact of socioeconomic position & maternal morbidity in Australia 2New study examines the impact of socioeconomic position & maternal morbidity in Australia 3Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 2Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 3Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 4Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 5
... researcher, Dr. Mark Flynn,s high-speed flywheel motor controller is ... the world. Flynn,s design has been incorporated into energy ... and sold by VYCON Inc. The 8,000 RTG ... significantly to port emissions and, as such, have ...
... an international group of colleagues to delay their race ... 7,000-hour slog through a compendium of 50,000 scientific articles ... that might herald the furtive presence of pancreatic cancer. ... and expensive testing that needs to be done before ...
... (ASM) will hold its 109th General Meeting May ... feature approximately 3,000 individual scientific presentations spanning the ... of 10,000. Microbiologists study living organisms and ... human and animal health, agriculture, the environment and ...
Cached Biology News:Saving energy and the environment with Flywheels 2Compendium of pancreatic cancer biomarkers established as strategic approach to early-detection 2Compendium of pancreatic cancer biomarkers established as strategic approach to early-detection 3
... identification Service includes 1. Scanning of ... 3. High-sensitive tryptic in-gel digestion and ... for MALDI-MS 5. Acquisition of PMF ... (Bruker ultraflex TOF/TOF) 6. Acquisition of ...
Each Yeast-GFP clone represents an individual S. cerevisiae strain containing an open reading frame with a C-terminal Aequorea Victoria GFP (S65T) fusion tag....
... number is a new product number, ... number. If showing no availability yet, ... number (R4276) or contact customer service ... (expanded surface, easy grip) ...
... stored within neurons in vesicles called ... the synaptic bouton. Synaptosomes may ... from other cellular debris. Abnormalites in ... many pathological condtions. Conditions of ...
Biology Products: